Sen. Lankford: Senate Republicans - Unprecedented Drug Price Control Scheme Threatens Innovation, Future Drug Costs
September 15, 2022
September 15, 2022
WASHINGTON, Sept. 15 -- Sen. James Lankford, R-Oklahoma, issued the following news release and letter:
Senate Republicans, including Senator James Lankford (R-OK), are expressing concerns with the establishment of a permanent government price-setting program, funded by billions of taxpayer dollars, in the partisan Inflation Reduction Act, and raising questions regarding federal health agencies' plans for program implementation.
In a letter to Health and Human Servi . . .
Senate Republicans, including Senator James Lankford (R-OK), are expressing concerns with the establishment of a permanent government price-setting program, funded by billions of taxpayer dollars, in the partisan Inflation Reduction Act, and raising questions regarding federal health agencies' plans for program implementation.
In a letter to Health and Human Servi . . .